New Antifungal Drugs, New Approaches and Vaccines

Review: Developing a vaccine against aspergillosis

28 January 2016

Nebulized Liposomal Amphotericin B Prophylaxis for Aspergillus Infection in Lung Transplantation: Pharmacokinetics and Safety

1 February 2009

Aerosolized liposomal Amphotericin B: a potential prophylaxis of invasive pulmonary aspergillosis in immunocompromised patients.

1 June 2014

Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant Recipients

Phase 3

6 October 2005

A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis

Phase 3

13 May 2013

Inhalation of Liposomal Amphotericin B to Prevent Invasive Aspergillosis

Phase 3

7 December 2005

Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis (AMBINEB)

Phase 2

20 October 2006

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

Phase 2

4 June 2012

Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates.

15 July 2015

NP213 (Novexatin)

Phase 2

25 January 2016